在多药同步输液过程中对布托尔法诺,尼卡迪平,乌拉皮迪尔和蒂罗菲班的兼容性和稳定性研究
Xiaoyu Zhao1,2, Liting Zhang1,2, Siqi Yu1,2
1School of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, People's Republic of China.
Drug design, development and therapy
|March 10, 2026
概括
这项研究评估了ICU药物输注的稳定性. 虽然大多数组合在24小时内保持稳定,但尼卡迪平化水表现出降解,需要对某些混合物进行输液时间限制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 密集护理医学 密集护理医学
背景情况:
- 重症监护室 (ICU) 通常需要同时服用多种静脉注射药物.
- 确保这些药物组合的物理化学稳定性和兼容性对于患者的安全性和治疗疗效至关重要.
- 关于在重症监护机构使用的特定多种药物输注的稳定性数据有限.
研究的目的:
- 为了评估丁醇酸盐,尼卡迪平化,乌拉皮迪尔和蒂罗菲班化组合的物理化学稳定性和兼容性.
- 提供基于证据的建议,以确保这些药物的安全输注在ICU中的做法.
- 为了确定同时给药对药物度随着时间的推移的影响.
主要方法:
- 在0.9%的化注射中制备四,三和两种药物组合.
- 模拟的临床条件:室温,没有光线.
- 评估不同时间点 (0-24小时) 的外观,pH值和不溶性颗粒数量.
- 使用高性能液态染色学 (HPLC) 对药物度的定量分析.
主要成果:
- 所有测试的药物组合都在24小时内保持了物理稳定性 (外观,pH,颗粒).
- 在特定组合中观察到尼卡迪平化的显著降解,在24小时内降低到基线度的80%以下.
- 在大多数测试混合物中,丁醇酸盐,乌拉皮迪尔和蒂罗菲班化物度保持稳定 (高于初始值的90%).
结论:
- 甲醇酸与在测试条件下研究的其他药物兼容.
- 尼卡迪平化与蒂罗菲班化的输液应限制在8小时内.
- 尼卡迪平化与乌拉皮迪尔和蒂罗菲班化的输液不应超过12小时;其他组合最多稳定24小时.
相关概念视频
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
323
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
323
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
305
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
235
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
235
IV Infusion to Oral Dosing: Conversion Methods
113
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
113
Bioequivalence of Drugs: Drugs with Multiple Indications
203
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
203
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K


